Gene Symbol | Gene ID | Gene Info |
---|---|---|
E2f7
|
ENSMUSG00000020185.10 | E2F transcription factor 7 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr10_110706957_110707108 | E2f7 | 38407 | 0.161183 | -0.41 | 1.0e-03 | Click! |
chr10_110745526_110746136 | E2f7 | 259 | 0.936586 | 0.32 | 1.3e-02 | Click! |
chr10_110744898_110745360 | E2f7 | 310 | 0.918377 | 0.30 | 2.1e-02 | Click! |
chr10_110707616_110707826 | E2f7 | 37718 | 0.163071 | -0.26 | 4.2e-02 | Click! |
chr10_110735525_110735834 | E2f7 | 9760 | 0.231223 | -0.24 | 6.3e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_80128704_80129752 | 5.16 |
Pde1a |
phosphodiesterase 1A, calmodulin-dependent |
230 |
0.94 |
chr18_69349496_69350227 | 5.02 |
Tcf4 |
transcription factor 4 |
917 |
0.69 |
chr18_65582281_65582868 | 4.55 |
Zfp532 |
zinc finger protein 532 |
39 |
0.95 |
chr5_37821115_37822599 | 4.30 |
Msx1 |
msh homeobox 1 |
2725 |
0.28 |
chr5_19907724_19909563 | 4.15 |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
682 |
0.82 |
chr18_46211646_46212763 | 4.13 |
Trim36 |
tripartite motif-containing 36 |
403 |
0.84 |
chr18_77564268_77564635 | 3.99 |
Rnf165 |
ring finger protein 165 |
158 |
0.96 |
chr8_14382368_14383445 | 3.89 |
Dlgap2 |
DLG associated protein 2 |
910 |
0.66 |
chr3_17790150_17790808 | 3.76 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
522 |
0.77 |
chr3_49756079_49757232 | 3.72 |
Pcdh18 |
protocadherin 18 |
628 |
0.76 |
chr10_69705909_69707430 | 3.67 |
Ank3 |
ankyrin 3, epithelial |
191 |
0.97 |
chr18_8871366_8872147 | 3.65 |
Gm37148 |
predicted gene, 37148 |
56479 |
0.14 |
chr5_37716516_37717529 | 3.63 |
Stk32b |
serine/threonine kinase 32B |
149 |
0.96 |
chrX_61116034_61117613 | 3.59 |
Cdr1os |
cerebellar degeneration related antigen 1, opposite strand |
425 |
0.47 |
chr8_70691465_70691881 | 3.59 |
Jund |
jun D proto-oncogene |
7276 |
0.08 |
chr8_99414293_99414856 | 3.58 |
Cdh8 |
cadherin 8 |
1745 |
0.36 |
chr7_73393483_73394074 | 3.56 |
Rgma |
repulsive guidance molecule family member A |
2502 |
0.19 |
chr2_136058799_136059736 | 3.55 |
Lamp5 |
lysosomal-associated membrane protein family, member 5 |
164 |
0.96 |
chr13_42709240_42709536 | 3.51 |
Phactr1 |
phosphatase and actin regulator 1 |
155 |
0.97 |
chr7_44443183_44443767 | 3.42 |
Lrrc4b |
leucine rich repeat containing 4B |
738 |
0.4 |
chrX_58030987_58032527 | 3.37 |
Zic3 |
zinc finger protein of the cerebellum 3 |
747 |
0.74 |
chr8_106336310_106337932 | 3.37 |
Smpd3 |
sphingomyelin phosphodiesterase 3, neutral |
867 |
0.61 |
chr13_40731940_40732438 | 3.36 |
Tfap2a |
transcription factor AP-2, alpha |
582 |
0.59 |
chr2_54437392_54437697 | 3.35 |
Galnt13 |
polypeptide N-acetylgalactosaminyltransferase 13 |
1053 |
0.65 |
chr6_6878154_6880927 | 3.35 |
Dlx5 |
distal-less homeobox 5 |
2528 |
0.19 |
chr13_83727321_83728283 | 3.31 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
304 |
0.83 |
chr13_105444000_105445296 | 3.28 |
Htr1a |
5-hydroxytryptamine (serotonin) receptor 1A |
1009 |
0.69 |
chr17_90087597_90088717 | 3.26 |
Nrxn1 |
neurexin I |
17 |
0.99 |
chr14_3948807_3949490 | 3.24 |
Gm3095 |
predicted gene 3095 |
14399 |
0.11 |
chrX_110816292_110817145 | 3.21 |
Pou3f4 |
POU domain, class 3, transcription factor 4 |
2438 |
0.34 |
chr18_69347722_69348433 | 3.15 |
Tcf4 |
transcription factor 4 |
179 |
0.97 |
chr9_102353147_102354512 | 3.14 |
Ephb1 |
Eph receptor B1 |
864 |
0.59 |
chr9_76322366_76323081 | 3.11 |
Hcrtr2 |
hypocretin (orexin) receptor 2 |
599 |
0.76 |
chr6_147261988_147262635 | 3.09 |
Pthlh |
parathyroid hormone-like peptide |
1856 |
0.31 |
chr2_97470022_97470462 | 3.08 |
Lrrc4c |
leucine rich repeat containing 4C |
2153 |
0.46 |
chr18_72349127_72350542 | 3.07 |
Dcc |
deleted in colorectal carcinoma |
1183 |
0.64 |
chr14_5001091_5002073 | 3.00 |
Gm3298 |
predicted gene 3298 |
14309 |
0.13 |
chrX_165326738_165328112 | 3.00 |
Glra2 |
glycine receptor, alpha 2 subunit |
32 |
0.99 |
chr12_76073039_76073683 | 3.00 |
Syne2 |
spectrin repeat containing, nuclear envelope 2 |
1345 |
0.51 |
chr8_96455054_96456367 | 2.95 |
Gm32122 |
predicted gene, 32122 |
51848 |
0.14 |
chr8_84179852_84181199 | 2.95 |
Mir181c |
microRNA 181c |
1564 |
0.13 |
chr16_44565348_44566291 | 2.92 |
Boc |
biregional cell adhesion molecule-related/down-regulated by oncogenes (Cdon) binding protein |
6922 |
0.21 |
chr1_159523756_159524611 | 2.92 |
Tnr |
tenascin R |
342 |
0.91 |
chr4_25799045_25800424 | 2.91 |
Fut9 |
fucosyltransferase 9 |
121 |
0.96 |
chr5_111421306_111422790 | 2.90 |
Gm43119 |
predicted gene 43119 |
1541 |
0.35 |
chr10_80385408_80385703 | 2.88 |
Mex3d |
mex3 RNA binding family member D |
2104 |
0.11 |
chr1_72873610_72874834 | 2.88 |
Igfbp5 |
insulin-like growth factor binding protein 5 |
53 |
0.98 |
chr13_83713629_83714389 | 2.87 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
7372 |
0.14 |
chr12_117150370_117151613 | 2.87 |
Gm10421 |
predicted gene 10421 |
224 |
0.96 |
chr7_137312340_137312685 | 2.83 |
Ebf3 |
early B cell factor 3 |
1404 |
0.43 |
chr9_4794566_4795419 | 2.82 |
Gria4 |
glutamate receptor, ionotropic, AMPA4 (alpha 4) |
527 |
0.88 |
chr3_80800286_80803016 | 2.82 |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
928 |
0.67 |
chr14_4649261_4650460 | 2.78 |
Gm3239 |
predicted gene 3239 |
14332 |
0.11 |
chr6_53288842_53289356 | 2.78 |
Creb5 |
cAMP responsive element binding protein 5 |
1324 |
0.55 |
chr1_79439702_79440415 | 2.77 |
Scg2 |
secretogranin II |
16 |
0.98 |
chrX_136666183_136667703 | 2.75 |
Tceal3 |
transcription elongation factor A (SII)-like 3 |
332 |
0.84 |
chr13_83717521_83718816 | 2.71 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
3213 |
0.17 |
chr5_26817077_26818245 | 2.71 |
Dpp6 |
dipeptidylpeptidase 6 |
227 |
0.94 |
chrX_135209330_135210111 | 2.66 |
Tceal6 |
transcription elongation factor A (SII)-like 6 |
967 |
0.45 |
chr3_119782089_119782365 | 2.66 |
Ptbp2 |
polypyrimidine tract binding protein 2 |
1007 |
0.5 |
chrX_133684830_133685971 | 2.65 |
Pcdh19 |
protocadherin 19 |
409 |
0.91 |
chr1_79450112_79451070 | 2.64 |
Scg2 |
secretogranin II |
10471 |
0.24 |
chr7_79501250_79502506 | 2.64 |
Mir9-3hg |
Mir9-3 host gene |
1757 |
0.18 |
chr8_61226832_61226983 | 2.64 |
Sh3rf1 |
SH3 domain containing ring finger 1 |
2663 |
0.29 |
chr2_120244697_120245562 | 2.63 |
Pla2g4e |
phospholipase A2, group IVE |
21 |
0.89 |
chr2_90886739_90886966 | 2.63 |
C1qtnf4 |
C1q and tumor necrosis factor related protein 4 |
992 |
0.36 |
chr16_5884597_5886147 | 2.62 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
17 |
0.99 |
chr3_94413310_94413753 | 2.61 |
Gm42463 |
predicted gene 42463 |
130 |
0.55 |
chr18_72350573_72351222 | 2.61 |
Dcc |
deleted in colorectal carcinoma |
120 |
0.98 |
chr2_6883618_6884699 | 2.60 |
Gm13389 |
predicted gene 13389 |
112 |
0.85 |
chr7_79498955_79500626 | 2.60 |
Mir9-3hg |
Mir9-3 host gene |
236 |
0.84 |
chr4_45825879_45827166 | 2.58 |
Igfbpl1 |
insulin-like growth factor binding protein-like 1 |
401 |
0.81 |
chr14_4855192_4856263 | 2.57 |
Gm3264 |
predicted gene 3264 |
151 |
0.94 |
chr13_28882060_28882913 | 2.56 |
2610307P16Rik |
RIKEN cDNA 2610307P16 gene |
970 |
0.55 |
chr1_42686011_42687379 | 2.56 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
6398 |
0.14 |
chr13_78189592_78191761 | 2.54 |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
233 |
0.9 |
chr2_91930544_91931926 | 2.53 |
Mdk |
midkine |
453 |
0.69 |
chr1_128590826_128591188 | 2.52 |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
1283 |
0.49 |
chr17_91092075_91093120 | 2.52 |
Nrxn1 |
neurexin I |
136 |
0.95 |
chr14_3571642_3572719 | 2.51 |
Gm3005 |
predicted gene 3005 |
157 |
0.94 |
chr5_142964424_142964601 | 2.50 |
Fscn1 |
fascin actin-bundling protein 1 |
21 |
0.97 |
chr1_138840496_138840948 | 2.48 |
Lhx9 |
LIM homeobox protein 9 |
1707 |
0.3 |
chr15_44787203_44788294 | 2.46 |
A930017M01Rik |
RIKEN cDNA A930017M01 gene |
21 |
0.83 |
chr3_34641628_34643070 | 2.45 |
Gm42692 |
predicted gene 42692 |
915 |
0.41 |
chr14_93889749_93891606 | 2.45 |
Pcdh9 |
protocadherin 9 |
2 |
0.99 |
chr14_29718651_29719941 | 2.44 |
Cacna2d3 |
calcium channel, voltage-dependent, alpha2/delta subunit 3 |
2499 |
0.26 |
chr1_11413602_11414901 | 2.43 |
A830018L16Rik |
RIKEN cDNA A830018L16 gene |
18 |
0.98 |
chr1_75381750_75382029 | 2.43 |
Speg |
SPEG complex locus |
225 |
0.87 |
chr5_114090407_114091746 | 2.42 |
Svop |
SV2 related protein |
291 |
0.84 |
chr5_142813894_142814702 | 2.42 |
Tnrc18 |
trinucleotide repeat containing 18 |
3082 |
0.23 |
chr5_112394277_112394516 | 2.40 |
Asphd2 |
aspartate beta-hydroxylase domain containing 2 |
95 |
0.94 |
chr13_81632543_81633660 | 2.40 |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
38 |
0.98 |
chr12_108000728_108001440 | 2.40 |
Bcl11b |
B cell leukemia/lymphoma 11B |
2330 |
0.41 |
chr14_122480308_122481080 | 2.38 |
Zic2 |
zinc finger protein of the cerebellum 2 |
2594 |
0.16 |
chr2_66439804_66441087 | 2.36 |
Scn1a |
sodium channel, voltage-gated, type I, alpha |
369 |
0.52 |
chr3_89226055_89227441 | 2.36 |
Mtx1 |
metaxin 1 |
304 |
0.42 |
chr6_136171767_136172200 | 2.36 |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
94 |
0.95 |
chr7_45361171_45362452 | 2.34 |
Ppfia3 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 |
11 |
0.92 |
chr13_109116105_109117683 | 2.34 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
253 |
0.96 |
chr10_106469534_106470969 | 2.34 |
Ppfia2 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2 |
88 |
0.97 |
chr7_51621596_51622924 | 2.32 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
39 |
0.98 |
chr2_62046631_62048214 | 2.32 |
Slc4a10 |
solute carrier family 4, sodium bicarbonate cotransporter-like, member 10 |
777 |
0.76 |
chr4_122997590_122997967 | 2.31 |
Mycl |
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived |
1102 |
0.42 |
chr4_24966704_24967200 | 2.31 |
C230012O17Rik |
RIKEN cDNA C230012O17 gene |
131 |
0.74 |
chr14_3809696_3810741 | 2.30 |
Gm3002 |
predicted gene 3002 |
144 |
0.94 |
chr14_4726384_4727541 | 2.29 |
Gm3252 |
predicted gene 3252 |
187 |
0.91 |
chr7_84528418_84529713 | 2.29 |
Gm2115 |
predicted gene 2115 |
73 |
0.97 |
chr4_97745473_97745954 | 2.29 |
Gm12676 |
predicted gene 12676 |
11676 |
0.21 |
chrX_36195589_36196935 | 2.28 |
Zcchc12 |
zinc finger, CCHC domain containing 12 |
276 |
0.9 |
chrX_48519996_48520368 | 2.27 |
Rab33a |
RAB33A, member RAS oncogene family |
897 |
0.55 |
chr8_62951127_62952454 | 2.25 |
Spock3 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 3 |
10 |
0.98 |
chr6_77244137_77244322 | 2.24 |
Lrrtm1 |
leucine rich repeat transmembrane neuronal 1 |
1307 |
0.55 |
chr8_70317565_70317878 | 2.23 |
Cers1 |
ceramide synthase 1 |
629 |
0.54 |
chr8_121649714_121650258 | 2.22 |
Zcchc14 |
zinc finger, CCHC domain containing 14 |
2915 |
0.16 |
chr14_122481884_122483266 | 2.22 |
Zic2 |
zinc finger protein of the cerebellum 2 |
4475 |
0.12 |
chr14_6426291_6427481 | 2.22 |
Lamtor3-ps |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 3, pseudogene |
14404 |
0.14 |
chr17_48932346_48933546 | 2.22 |
Lrfn2 |
leucine rich repeat and fibronectin type III domain containing 2 |
567 |
0.85 |
chr9_41579927_41580714 | 2.21 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
342 |
0.73 |
chr11_81968072_81969328 | 2.21 |
Asic2 |
acid-sensing (proton-gated) ion channel 2 |
243 |
0.91 |
chr11_44398909_44399280 | 2.19 |
Il12b |
interleukin 12b |
969 |
0.55 |
chr7_137308529_137308823 | 2.19 |
Ebf3 |
early B cell factor 3 |
5240 |
0.21 |
chr14_4498814_4499998 | 2.18 |
Gm3173 |
predicted gene 3173 |
15352 |
0.11 |
chr2_158606690_158608449 | 2.18 |
Gm14204 |
predicted gene 14204 |
3021 |
0.15 |
chr7_109010570_109010827 | 2.18 |
Tub |
tubby bipartite transcription factor |
127 |
0.96 |
chr2_84741934_84742491 | 2.18 |
Mir130a |
microRNA 130a |
1034 |
0.27 |
chr16_94996546_94998023 | 2.17 |
Kcnj6 |
potassium inwardly-rectifying channel, subfamily J, member 6 |
32 |
0.99 |
chr10_80226705_80227856 | 2.17 |
Pwwp3a |
PWWP domain containing 3A, DNA repair factor |
529 |
0.58 |
chr5_116589538_116590511 | 2.16 |
Srrm4 |
serine/arginine repetitive matrix 4 |
1793 |
0.34 |
chrX_134404822_134405180 | 2.16 |
Drp2 |
dystrophin related protein 2 |
199 |
0.94 |
chr11_118908287_118909561 | 2.15 |
Rbfox3 |
RNA binding protein, fox-1 homolog (C. elegans) 3 |
626 |
0.73 |
chr16_28445086_28445617 | 2.13 |
Fgf12 |
fibroblast growth factor 12 |
724 |
0.81 |
chr14_67236008_67239452 | 2.13 |
Ebf2 |
early B cell factor 2 |
3086 |
0.21 |
chr3_66977838_66980287 | 2.13 |
Shox2 |
short stature homeobox 2 |
251 |
0.9 |
chr7_99267573_99269343 | 2.13 |
Map6 |
microtubule-associated protein 6 |
52 |
0.95 |
chr14_70658803_70660096 | 2.13 |
Npm2 |
nucleophosmin/nucleoplasmin 2 |
205 |
0.9 |
chr11_103884679_103885346 | 2.12 |
Gm8738 |
predicted gene 8738 |
4769 |
0.22 |
chr8_58911260_58911448 | 2.11 |
Galntl6 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6 |
222 |
0.7 |
chr13_8202516_8203999 | 2.11 |
Adarb2 |
adenosine deaminase, RNA-specific, B2 |
335 |
0.87 |
chr14_4018473_4019517 | 2.10 |
Gm5796 |
predicted gene 5796 |
4946 |
0.14 |
chr14_6107781_6108962 | 2.09 |
Gm3468 |
predicted gene 3468 |
294 |
0.84 |
chr10_109832096_109833441 | 2.09 |
Nav3 |
neuron navigator 3 |
453 |
0.9 |
chr2_140666876_140668088 | 2.08 |
Flrt3 |
fibronectin leucine rich transmembrane protein 3 |
3918 |
0.37 |
chr7_28104523_28105198 | 2.07 |
Fcgbp |
Fc fragment of IgG binding protein |
4051 |
0.13 |
chr13_69740286_69740844 | 2.07 |
Ube2ql1 |
ubiquitin-conjugating enzyme E2Q family-like 1 |
676 |
0.59 |
chr7_97842700_97844158 | 2.07 |
Pak1 |
p21 (RAC1) activated kinase 1 |
494 |
0.83 |
chr15_95527528_95528774 | 2.06 |
Nell2 |
NEL-like 2 |
27 |
0.99 |
chr8_71685721_71686960 | 2.05 |
Insl3 |
insulin-like 3 |
2874 |
0.12 |
chr12_107997791_107998940 | 2.04 |
Bcl11b |
B cell leukemia/lymphoma 11B |
5049 |
0.31 |
chrX_86191680_86192868 | 2.04 |
Nr0b1 |
nuclear receptor subfamily 0, group B, member 1 |
510 |
0.82 |
chr5_98180058_98181966 | 2.04 |
Prdm8 |
PR domain containing 8 |
34 |
0.97 |
chr13_107247429_107247791 | 2.04 |
Gm2726 |
predicted gene 2726 |
32581 |
0.2 |
chr2_25580658_25582212 | 2.04 |
Ajm1 |
apical junction component 1 |
293 |
0.72 |
chr9_81863064_81864426 | 2.04 |
Mei4 |
meiotic double-stranded break formation protein 4 |
36 |
0.98 |
chr4_15880938_15882113 | 2.02 |
Calb1 |
calbindin 1 |
259 |
0.9 |
chr16_67618825_67619284 | 2.02 |
Cadm2 |
cell adhesion molecule 2 |
1439 |
0.51 |
chr4_62966572_62967137 | 2.02 |
Zfp618 |
zinc finger protein 618 |
1280 |
0.42 |
chr3_69597941_69598796 | 2.01 |
B3galnt1 |
UDP-GalNAc:betaGlcNAc beta 1,3-galactosaminyltransferase, polypeptide 1 |
592 |
0.74 |
chr1_172520580_172521084 | 2.01 |
Cfap45 |
cilia and flagella associated protein 45 |
31 |
0.95 |
chr7_5056231_5057716 | 2.00 |
Gm15510 |
predicted gene 15510 |
53 |
0.48 |
chr9_41474743_41475732 | 2.00 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
177 |
0.72 |
chr7_62420525_62420893 | 1.99 |
Mkrn3 |
makorin, ring finger protein, 3 |
570 |
0.69 |
chr12_95691954_95693678 | 1.99 |
Flrt2 |
fibronectin leucine rich transmembrane protein 2 |
590 |
0.73 |
chr5_131535782_131536209 | 1.99 |
Auts2 |
autism susceptibility candidate 2 |
1598 |
0.38 |
chr8_93810943_93811954 | 1.98 |
Gnao1 |
guanine nucleotide binding protein, alpha O |
135 |
0.93 |
chr13_48262938_48263089 | 1.97 |
A330033J07Rik |
RIKEN cDNA A330033J07 gene |
390 |
0.47 |
chr3_13946382_13947629 | 1.97 |
Ralyl |
RALY RNA binding protein-like |
594 |
0.84 |
chr15_101076799_101077203 | 1.97 |
Fignl2 |
fidgetin-like 2 |
1566 |
0.3 |
chr8_122750756_122751439 | 1.96 |
C230057M02Rik |
RIKEN cDNA C230057M02 gene |
1228 |
0.3 |
chr13_36726546_36727935 | 1.96 |
Gm30177 |
predicted gene, 30177 |
18 |
0.97 |
chr14_99022496_99022928 | 1.95 |
Mzt1 |
mitotic spindle organizing protein 1 |
23240 |
0.14 |
chr6_134863030_134863674 | 1.95 |
Crebl2 |
cAMP responsive element binding protein-like 2 |
12194 |
0.11 |
chr16_59639765_59639916 | 1.95 |
Arl6 |
ADP-ribosylation factor-like 6 |
449 |
0.58 |
chr11_101466246_101466397 | 1.94 |
Vat1 |
vesicle amine transport 1 |
91 |
0.88 |
chr3_149191254_149191476 | 1.94 |
Gm42647 |
predicted gene 42647 |
18906 |
0.21 |
chr15_97993365_97993717 | 1.94 |
Col2a1 |
collagen, type II, alpha 1 |
3065 |
0.22 |
chr12_73040722_73041603 | 1.94 |
Six1 |
sine oculis-related homeobox 1 |
1653 |
0.39 |
chr15_98003545_98005314 | 1.94 |
Col2a1 |
collagen, type II, alpha 1 |
62 |
0.97 |
chr1_186702387_186703121 | 1.94 |
Tgfb2 |
transforming growth factor, beta 2 |
1579 |
0.29 |
chr3_108535862_108537093 | 1.93 |
5330417C22Rik |
RIKEN cDNA 5330417C22 gene |
18 |
0.92 |
chr5_120430812_120431653 | 1.92 |
Lhx5 |
LIM homeobox protein 5 |
467 |
0.48 |
chrX_166584612_166586034 | 1.92 |
Egfl6 |
EGF-like-domain, multiple 6 |
397 |
0.85 |
chr14_5070665_5071726 | 1.91 |
Gm8281 |
predicted gene, 8281 |
155 |
0.94 |
chr6_134886811_134888239 | 1.90 |
Gpr19 |
G protein-coupled receptor 19 |
243 |
0.87 |
chr14_6889307_6890296 | 1.90 |
Gm3667 |
predicted gene 3667 |
161 |
0.95 |
chr14_78732846_78733142 | 1.89 |
Dgkh |
diacylglycerol kinase, eta |
218 |
0.93 |
chr13_49319308_49320561 | 1.89 |
Fgd3 |
FYVE, RhoGEF and PH domain containing 3 |
377 |
0.86 |
chr5_49284738_49286021 | 1.88 |
Kcnip4 |
Kv channel interacting protein 4 |
280 |
0.92 |
chr6_42323611_42324574 | 1.88 |
Fam131b |
family with sequence similarity 131, member B |
500 |
0.63 |
chr7_80114068_80114684 | 1.87 |
Idh2 |
isocitrate dehydrogenase 2 (NADP+), mitochondrial |
928 |
0.39 |
chr2_106193921_106195187 | 1.86 |
Dcdc5 |
doublecortin domain containing 5 |
27503 |
0.21 |
chr14_84444241_84444671 | 1.86 |
Pcdh17 |
protocadherin 17 |
893 |
0.66 |
chr5_22746211_22746970 | 1.86 |
A930003O13Rik |
RIKEN cDNA A930003O13 gene |
297 |
0.65 |
chr6_36808050_36808542 | 1.86 |
Ptn |
pleiotrophin |
1883 |
0.46 |
chr13_78182771_78183170 | 1.86 |
Gm38604 |
predicted gene, 38604 |
189 |
0.92 |
chr4_22485878_22486449 | 1.86 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
2203 |
0.26 |
chr14_122484799_122486138 | 1.85 |
Gm10837 |
predicted gene 10837 |
5118 |
0.12 |
chr5_66747744_66748929 | 1.85 |
Limch1 |
LIM and calponin homology domains 1 |
2447 |
0.26 |
chr2_164679355_164679640 | 1.85 |
Wfdc11 |
WAP four-disulfide core domain 11 |
5410 |
0.08 |
chr9_41585694_41587243 | 1.85 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
1301 |
0.29 |
chr7_16611263_16612711 | 1.85 |
Gm29443 |
predicted gene 29443 |
1837 |
0.17 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.8 | 11.4 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
1.6 | 6.6 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
1.5 | 4.4 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.4 | 10.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.3 | 5.1 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
1.1 | 5.3 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
1.0 | 5.2 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.0 | 3.1 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.0 | 5.0 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
1.0 | 3.9 | GO:0060174 | limb bud formation(GO:0060174) |
1.0 | 1.9 | GO:0060166 | olfactory pit development(GO:0060166) |
1.0 | 1.0 | GO:0070384 | Harderian gland development(GO:0070384) |
0.9 | 2.8 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.9 | 3.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.9 | 0.9 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.9 | 1.8 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.9 | 1.7 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.9 | 1.7 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.8 | 1.7 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.8 | 2.5 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.8 | 6.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.8 | 2.5 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.8 | 3.2 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.8 | 2.4 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.8 | 3.1 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.8 | 0.8 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.8 | 8.4 | GO:0060013 | righting reflex(GO:0060013) |
0.7 | 4.5 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.7 | 6.7 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.7 | 0.7 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.7 | 2.2 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.7 | 2.9 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.7 | 2.1 | GO:0021586 | pons maturation(GO:0021586) |
0.7 | 3.5 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.7 | 2.8 | GO:0046909 | intermembrane transport(GO:0046909) |
0.7 | 2.0 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.7 | 2.0 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.6 | 2.6 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.6 | 2.6 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.6 | 0.6 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.6 | 1.9 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.6 | 3.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.6 | 2.5 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.6 | 3.1 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.6 | 1.2 | GO:0030421 | defecation(GO:0030421) |
0.6 | 2.5 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.6 | 6.7 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.6 | 2.4 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.6 | 5.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.6 | 1.2 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
0.6 | 3.5 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.6 | 1.7 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.6 | 3.4 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.6 | 1.7 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.6 | 1.7 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.6 | 1.1 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.6 | 1.7 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.5 | 2.2 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.5 | 2.7 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.5 | 1.6 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.5 | 1.1 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.5 | 1.6 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.5 | 1.1 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
0.5 | 2.6 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.5 | 4.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.5 | 1.0 | GO:0060594 | mammary gland specification(GO:0060594) |
0.5 | 1.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.5 | 1.5 | GO:0015888 | thiamine transport(GO:0015888) |
0.5 | 1.5 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.5 | 2.5 | GO:0048840 | otolith development(GO:0048840) |
0.5 | 0.5 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.5 | 1.0 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.5 | 1.9 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.5 | 2.4 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.5 | 1.9 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.5 | 1.0 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.5 | 2.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.5 | 1.9 | GO:0007412 | axon target recognition(GO:0007412) |
0.5 | 2.8 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.5 | 1.9 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.5 | 2.3 | GO:0035989 | tendon development(GO:0035989) |
0.5 | 1.9 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.5 | 2.3 | GO:0038107 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.5 | 2.3 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.5 | 0.9 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.5 | 1.4 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.5 | 1.4 | GO:0090427 | activation of meiosis(GO:0090427) |
0.5 | 5.1 | GO:0036065 | fucosylation(GO:0036065) |
0.5 | 1.9 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.5 | 1.4 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.5 | 1.4 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.5 | 1.4 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.4 | 0.9 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.4 | 0.9 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.4 | 1.3 | GO:0009629 | response to gravity(GO:0009629) |
0.4 | 1.3 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.4 | 4.4 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.4 | 0.4 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.4 | 0.9 | GO:0060027 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) convergent extension involved in gastrulation(GO:0060027) |
0.4 | 1.3 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.4 | 1.7 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.4 | 2.1 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.4 | 2.1 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.4 | 1.3 | GO:0040031 | snRNA modification(GO:0040031) |
0.4 | 1.7 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.4 | 0.4 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.4 | 2.1 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.4 | 2.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.4 | 7.0 | GO:0060074 | synapse maturation(GO:0060074) |
0.4 | 1.2 | GO:0010535 | positive regulation of activation of JAK2 kinase activity(GO:0010535) |
0.4 | 13.0 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.4 | 1.2 | GO:0046958 | nonassociative learning(GO:0046958) |
0.4 | 0.4 | GO:0060513 | prostatic bud formation(GO:0060513) |
0.4 | 1.6 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.4 | 5.6 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.4 | 1.2 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.4 | 1.2 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.4 | 6.7 | GO:0001964 | startle response(GO:0001964) |
0.4 | 2.0 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.4 | 1.2 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.4 | 3.1 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.4 | 0.8 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.4 | 1.1 | GO:0030070 | insulin processing(GO:0030070) |
0.4 | 0.4 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.4 | 2.3 | GO:0007614 | short-term memory(GO:0007614) |
0.4 | 0.4 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.4 | 1.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.4 | 1.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.4 | 1.8 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.4 | 3.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.4 | 4.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.4 | 5.8 | GO:0060384 | innervation(GO:0060384) |
0.4 | 1.1 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.4 | 2.5 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.4 | 0.7 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.4 | 0.7 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.4 | 0.7 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.4 | 1.1 | GO:0060437 | lung growth(GO:0060437) |
0.3 | 2.1 | GO:0034776 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.3 | 0.3 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.3 | 1.4 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.3 | 1.0 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.3 | 0.7 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.3 | 3.4 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.3 | 1.7 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.3 | 1.7 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.3 | 1.3 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.3 | 0.7 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.3 | 1.0 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.3 | 0.6 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.3 | 1.6 | GO:0060179 | male mating behavior(GO:0060179) |
0.3 | 0.9 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.3 | 0.9 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.3 | 0.9 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.3 | 0.6 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.3 | 0.9 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.3 | 3.1 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.3 | 2.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 0.6 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.3 | 0.6 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.3 | 0.9 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.3 | 0.9 | GO:0071625 | vocalization behavior(GO:0071625) |
0.3 | 0.6 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.3 | 0.9 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
0.3 | 2.9 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.3 | 2.6 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.3 | 0.6 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.3 | 1.2 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.3 | 0.9 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.3 | 0.3 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.3 | 0.6 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.3 | 0.9 | GO:0015755 | fructose transport(GO:0015755) |
0.3 | 1.4 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.3 | 13.5 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.3 | 0.9 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.3 | 0.3 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.3 | 0.6 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.3 | 0.3 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.3 | 0.6 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.3 | 0.6 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.3 | 0.8 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.3 | 1.4 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.3 | 1.4 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.3 | 0.8 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.3 | 0.8 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.3 | 3.6 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.3 | 0.8 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.3 | 1.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.3 | 1.4 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.3 | 0.5 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.3 | 1.1 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.3 | 4.0 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.3 | 20.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.3 | 0.3 | GO:0014060 | regulation of epinephrine secretion(GO:0014060) |
0.3 | 0.3 | GO:0072197 | ureter morphogenesis(GO:0072197) |
0.3 | 1.3 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.3 | 1.3 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.3 | 0.8 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.3 | 0.5 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.3 | 0.8 | GO:0015817 | histidine transport(GO:0015817) |
0.3 | 0.5 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.3 | 0.8 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.3 | 0.8 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.3 | 2.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 1.8 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.3 | 0.8 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) |
0.3 | 0.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 0.8 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.3 | 1.5 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.3 | 0.3 | GO:0060026 | convergent extension(GO:0060026) |
0.3 | 0.3 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.2 | 2.0 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 0.2 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.2 | 1.0 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.2 | 0.5 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.2 | 0.2 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.2 | 0.7 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.2 | 0.7 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.2 | 1.0 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 1.0 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.2 | 0.2 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.2 | 3.6 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.2 | 0.9 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.2 | 0.2 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.2 | 0.7 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.2 | 0.5 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.2 | 0.2 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.2 | 0.9 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 0.7 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.2 | 0.4 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.2 | 6.0 | GO:0019228 | neuronal action potential(GO:0019228) |
0.2 | 1.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.2 | 1.6 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.2 | 0.7 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.2 | 0.7 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.2 | 1.3 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 0.7 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.2 | 0.7 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.2 | 0.9 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
0.2 | 1.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.2 | 0.6 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 0.6 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 0.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 1.3 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.2 | 3.0 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.9 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.2 | 2.8 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.2 | 0.6 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.2 | 2.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 0.4 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.2 | 0.8 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.2 | 0.8 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.2 | 0.4 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 0.4 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.2 | 1.0 | GO:0046836 | glycolipid transport(GO:0046836) |
0.2 | 1.0 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.2 | 0.6 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.2 | 0.6 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 0.6 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.2 | 0.6 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.2 | 0.6 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.2 | 1.2 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.2 | 1.8 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.2 | 0.6 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.2 | 0.2 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 0.6 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.2 | 0.8 | GO:0030818 | negative regulation of cAMP biosynthetic process(GO:0030818) |
0.2 | 1.7 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.2 | 0.4 | GO:0021578 | hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
0.2 | 0.8 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.2 | 0.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 0.2 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.2 | 1.0 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.2 | 0.2 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.2 | 1.1 | GO:0070471 | uterine smooth muscle contraction(GO:0070471) regulation of uterine smooth muscle contraction(GO:0070472) |
0.2 | 2.3 | GO:0007616 | long-term memory(GO:0007616) |
0.2 | 0.2 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 0.8 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.2 | 0.6 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.2 | 1.9 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.2 | 0.4 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.2 | 0.6 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 2.6 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.2 | 0.7 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.2 | 0.7 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.2 | 0.6 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 0.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.2 | 3.1 | GO:0031114 | regulation of microtubule depolymerization(GO:0031114) |
0.2 | 10.2 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.2 | 1.5 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.2 | 0.5 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.2 | 0.2 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.2 | 0.7 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.2 | 0.9 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 0.4 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.2 | 0.7 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.2 | 0.5 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.2 | 0.4 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.2 | 1.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.2 | 0.5 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.2 | 0.5 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.2 | 0.5 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.2 | 0.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.2 | 1.0 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.2 | 0.5 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.2 | 0.5 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.2 | 0.3 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.2 | 0.5 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.2 | 1.5 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.2 | 1.5 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.2 | 0.5 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.2 | 0.7 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.2 | 0.8 | GO:0035640 | exploration behavior(GO:0035640) |
0.2 | 0.5 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.2 | 0.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.2 | 0.6 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.2 | 3.0 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.2 | 3.2 | GO:0060359 | response to ammonium ion(GO:0060359) |
0.2 | 0.2 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.2 | 2.7 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.2 | 0.5 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.2 | 0.2 | GO:1902488 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.2 | 0.5 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.2 | 1.7 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.2 | 0.5 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.2 | 0.3 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.2 | 0.5 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.2 | 0.5 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.2 | 0.8 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.2 | 0.5 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.2 | 0.8 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.2 | 0.3 | GO:2000849 | glucocorticoid secretion(GO:0035933) negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) regulation of glucocorticoid secretion(GO:2000849) negative regulation of glucocorticoid secretion(GO:2000850) |
0.2 | 0.5 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.2 | 0.5 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 2.8 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.1 | 0.4 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.1 | 0.7 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.9 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.3 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.1 | 0.7 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 | 0.6 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 0.1 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.7 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.6 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.1 | 1.3 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.1 | 0.6 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.4 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.1 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.1 | 0.1 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.1 | 0.4 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.1 | 1.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 1.0 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.1 | 0.4 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.4 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.1 | 0.6 | GO:0042220 | response to cocaine(GO:0042220) |
0.1 | 0.1 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
0.1 | 0.4 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 1.0 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.1 | 0.3 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.1 | 0.6 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.1 | 0.4 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.1 | 0.6 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.4 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.7 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.1 | 0.1 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.1 | 0.4 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.5 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.1 | 0.7 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.1 | 0.8 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 2.5 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.1 | 0.1 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.1 | 0.4 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 0.3 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.4 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.5 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.1 | 0.9 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.3 | GO:0036394 | amylase secretion(GO:0036394) |
0.1 | 0.8 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.1 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.1 | 0.9 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.4 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.1 | 0.5 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 1.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.4 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.1 | 0.3 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.1 | 0.4 | GO:0002254 | kinin cascade(GO:0002254) |
0.1 | 0.8 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.4 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.1 | 0.1 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.1 | 0.4 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.8 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 1.0 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) |
0.1 | 1.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 1.3 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.3 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.1 | 0.1 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.1 | 2.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.4 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.4 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.1 | 0.5 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.3 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 0.5 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.1 | 0.4 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.1 | 0.3 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.1 | 0.4 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.1 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 1.0 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.1 | 0.1 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.1 | 0.5 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 1.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.4 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.7 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.4 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.1 | 1.6 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.5 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.1 | 0.9 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.6 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.6 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 0.4 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.1 | 3.5 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.6 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 0.2 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.1 | 0.5 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.1 | 1.0 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 0.1 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.1 | 0.2 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 0.6 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.1 | 0.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.4 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.4 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.4 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.1 | 0.1 | GO:0021825 | substrate-dependent cerebral cortex tangential migration(GO:0021825) |
0.1 | 0.5 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.1 | 0.1 | GO:0043307 | eosinophil activation(GO:0043307) |
0.1 | 0.4 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.1 | 0.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.1 | 1.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.2 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.1 | 0.7 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.6 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.6 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.3 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 0.1 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.1 | 0.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 1.3 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.2 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.2 | GO:2000591 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.1 | 0.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.1 | 0.2 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.1 | 0.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.1 | 0.5 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.1 | 0.5 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 1.6 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.2 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.1 | 0.1 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.1 | 0.2 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 0.4 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.1 | 0.3 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 0.2 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.6 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.1 | 0.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.8 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 1.0 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.4 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.1 | 1.0 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 0.1 | GO:0015810 | aspartate transport(GO:0015810) |
0.1 | 0.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 0.3 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.3 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 1.6 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.3 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.2 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 0.1 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.6 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.1 | 0.4 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.1 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.1 | 0.2 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.1 | 0.2 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.1 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.7 | GO:1900364 | regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
0.1 | 0.3 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.1 | 1.2 | GO:0007416 | synapse assembly(GO:0007416) |
0.1 | 0.2 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.1 | 0.3 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 0.1 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.1 | 0.5 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.1 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.1 | 0.2 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 0.2 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.1 | 0.4 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.1 | 0.3 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.4 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 1.8 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.3 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.2 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.1 | 0.1 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.1 | 0.3 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.8 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 1.0 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.1 | 0.3 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.2 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.6 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.2 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.7 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 1.2 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.1 | 0.7 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.2 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.1 | 0.4 | GO:0043584 | nose development(GO:0043584) |
0.1 | 0.9 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.6 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.1 | 0.2 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.1 | 0.2 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 1.2 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.7 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.8 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.1 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.1 | 0.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 1.0 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.2 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.1 | 2.0 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 0.1 | GO:0010042 | response to manganese ion(GO:0010042) |
0.1 | 3.3 | GO:0007612 | learning(GO:0007612) |
0.1 | 1.4 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.7 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.1 | 0.2 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.1 | 0.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.3 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.1 | 0.5 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.1 | 0.2 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.2 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.1 | 0.2 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.1 | 0.1 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.1 | 0.5 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 0.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.4 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.8 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.1 | 0.1 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.1 | 0.3 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.1 | 0.3 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.1 | 1.8 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 0.5 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.3 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.1 | 0.3 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.1 | 0.5 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.4 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.1 | 0.8 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.2 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.1 | 0.8 | GO:0032402 | melanosome transport(GO:0032402) |
0.1 | 1.6 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.8 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.1 | 3.3 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 0.2 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.1 | 0.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.2 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 0.4 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.2 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 0.2 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.4 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.4 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.1 | 0.2 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.2 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.1 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.1 | 0.3 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.4 | GO:0099531 | presynaptic process involved in chemical synaptic transmission(GO:0099531) |
0.1 | 0.6 | GO:0006241 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.1 | 0.3 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.1 | 0.4 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.7 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.8 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.3 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.1 | 0.6 | GO:0021766 | hippocampus development(GO:0021766) |
0.1 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.1 | GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) |
0.1 | 2.5 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 0.2 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.4 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.2 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.1 | 0.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.2 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 2.0 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.1 | 0.2 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 0.1 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.1 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.2 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 | 0.1 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.1 | 0.2 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.1 | 0.4 | GO:0051588 | regulation of neurotransmitter transport(GO:0051588) |
0.1 | 0.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 0.2 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 0.9 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.2 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.1 | GO:0061197 | fungiform papilla morphogenesis(GO:0061197) |
0.1 | 0.3 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.1 | 0.4 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) cellular response to prostaglandin E stimulus(GO:0071380) |
0.1 | 0.3 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.1 | 0.6 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 0.4 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.1 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.1 | 0.7 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
0.1 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.3 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.1 | 0.3 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.1 | 0.8 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.1 | 0.9 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.1 | 0.6 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
0.1 | 0.3 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.1 | 0.4 | GO:0032328 | alanine transport(GO:0032328) |
0.1 | 0.5 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.1 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.1 | 0.4 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.7 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.3 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.1 | 0.1 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.1 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.1 | 0.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.5 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 0.1 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 0.2 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 0.2 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.2 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.1 | 0.4 | GO:1903671 | negative regulation of sprouting angiogenesis(GO:1903671) |
0.1 | 0.2 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.3 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.1 | 0.4 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 0.6 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 0.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 1.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.1 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.1 | 1.1 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.1 | 0.8 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 | 0.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.8 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.5 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 0.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.4 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.1 | 0.7 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 0.2 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.5 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 0.1 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.1 | 0.5 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.3 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.1 | 0.1 | GO:0072319 | vesicle uncoating(GO:0072319) |
0.1 | 0.2 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.3 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 0.1 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.1 | 0.4 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.1 | GO:0051029 | rRNA export from nucleus(GO:0006407) rRNA transport(GO:0051029) |
0.1 | 0.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.1 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 1.2 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.1 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.1 | 0.1 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.1 | 0.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.1 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.1 | 0.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.1 | 0.3 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) |
0.1 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.5 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.1 | 0.1 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.5 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.3 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.1 | 0.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.4 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.1 | 0.1 | GO:0030576 | Cajal body organization(GO:0030576) |
0.1 | 0.3 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.2 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.3 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 0.4 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 0.2 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.5 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.4 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.2 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 0.2 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.1 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.1 | 1.1 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 0.2 | GO:0008038 | neuron recognition(GO:0008038) |
0.1 | 0.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.1 | 0.9 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 1.0 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.1 | 0.2 | GO:0002063 | chondrocyte development(GO:0002063) |
0.1 | 0.2 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.0 | 0.0 | GO:0006228 | UTP biosynthetic process(GO:0006228) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) UTP metabolic process(GO:0046051) |
0.0 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.0 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.0 | 0.6 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.0 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.0 | 0.0 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.0 | 0.7 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.2 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.0 | 0.0 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.0 | 0.2 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.4 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.1 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.0 | 0.0 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.0 | 0.1 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.0 | 0.1 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.0 | 0.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.1 | GO:0010888 | negative regulation of lipid storage(GO:0010888) |
0.0 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.0 | 0.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.2 | GO:0090399 | replicative senescence(GO:0090399) |
0.0 | 0.2 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.0 | 0.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.1 | GO:0045738 | negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
0.0 | 0.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.0 | 1.2 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.2 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.0 | 0.1 | GO:1904502 | lipophagy(GO:0061724) regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.0 | 0.1 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.1 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.0 | 0.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 0.3 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.1 | GO:0061525 | hindgut development(GO:0061525) |
0.0 | 0.0 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.0 | 0.1 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 1.6 | GO:0050808 | synapse organization(GO:0050808) |
0.0 | 0.0 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
0.0 | 0.1 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.0 | 0.1 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.3 | GO:0051642 | centrosome localization(GO:0051642) |
0.0 | 0.1 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 0.4 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.0 | 0.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.2 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 0.1 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.0 | 0.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.0 | 0.2 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.0 | 0.1 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.1 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.0 | 0.3 | GO:0097369 | sodium ion import(GO:0097369) |
0.0 | 0.1 | GO:0080009 | mRNA methylation(GO:0080009) |
0.0 | 0.1 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.0 | 0.4 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.0 | 0.2 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.0 | 0.4 | GO:1903319 | positive regulation of protein maturation(GO:1903319) |
0.0 | 0.1 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.1 | GO:0043570 | meiotic mismatch repair(GO:0000710) maintenance of DNA repeat elements(GO:0043570) |
0.0 | 0.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:0060004 | reflex(GO:0060004) |
0.0 | 0.2 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.3 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.1 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.0 | 0.1 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.0 | 0.2 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.0 | 0.1 | GO:0030815 | negative regulation of cAMP metabolic process(GO:0030815) |
0.0 | 0.1 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
0.0 | 0.3 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.0 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.0 | 0.0 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.0 | 0.0 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.0 | 1.3 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.0 | 0.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.0 | 0.3 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.0 | 0.3 | GO:0032232 | negative regulation of actin filament bundle assembly(GO:0032232) |
0.0 | 1.1 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.4 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.1 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.0 | 0.2 | GO:2000193 | positive regulation of fatty acid transport(GO:2000193) |
0.0 | 0.5 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.1 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.0 | 0.1 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.0 | 0.7 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.1 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.0 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.0 | 0.0 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.1 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.0 | 0.0 | GO:0009648 | photoperiodism(GO:0009648) |
0.0 | 0.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.0 | 0.3 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.0 | 0.0 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 1.1 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.5 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.1 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.6 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.3 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.0 | 0.2 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.0 | 0.8 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.1 | GO:0090342 | regulation of cell aging(GO:0090342) |
0.0 | 0.0 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.0 | 0.1 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.0 | 0.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.0 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.0 | 0.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.1 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.0 | 0.1 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.0 | 0.1 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.0 | 0.1 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.0 | 0.1 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.0 | 0.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.0 | GO:0097061 | dendritic spine organization(GO:0097061) |
0.0 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.1 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.2 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.1 | GO:0016074 | snoRNA metabolic process(GO:0016074) |
0.0 | 0.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.1 | GO:0021795 | cerebral cortex cell migration(GO:0021795) |
0.0 | 0.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.0 | 0.0 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.1 | GO:0010288 | response to lead ion(GO:0010288) |
0.0 | 0.0 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.0 | 0.0 | GO:0002432 | granuloma formation(GO:0002432) |
0.0 | 0.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.0 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.0 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.0 | 0.1 | GO:0048021 | regulation of melanin biosynthetic process(GO:0048021) regulation of secondary metabolite biosynthetic process(GO:1900376) |
0.0 | 0.3 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.2 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.3 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.5 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.1 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.0 | 0.5 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.0 | 0.0 | GO:0045023 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) |
0.0 | 0.1 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.0 | 0.4 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.9 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.2 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.2 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.1 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.0 | 0.1 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
0.0 | 0.1 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 0.0 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.0 | 0.0 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.0 | 0.6 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.3 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.0 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.0 | 0.1 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.0 | 0.0 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.2 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.0 | 0.0 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
0.0 | 0.0 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.0 | 0.5 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.0 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.0 | 0.6 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.1 | GO:0003383 | apical constriction(GO:0003383) |
0.0 | 0.0 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.0 | 0.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.1 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.0 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.0 | 0.0 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.0 | 0.0 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.0 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.0 | 0.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.0 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.0 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.0 | 0.0 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.0 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.0 | 0.1 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.0 | 0.2 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.0 | 0.2 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.0 | 0.0 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.1 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 0.5 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.0 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.0 | GO:0002159 | desmosome assembly(GO:0002159) |
0.0 | 0.2 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.0 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.0 | 0.1 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.0 | 0.2 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.0 | 0.6 | GO:0043039 | tRNA aminoacylation(GO:0043039) |
0.0 | 0.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.0 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.0 | 0.0 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.0 | 0.0 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.0 | 0.1 | GO:0048478 | replication fork protection(GO:0048478) |
0.0 | 0.0 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.0 | 0.1 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.0 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.0 | 0.0 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.1 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 0.1 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 0.1 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.0 | 0.1 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.0 | 0.0 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.0 | 0.0 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.0 | 0.0 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.0 | 0.1 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.0 | 0.0 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.0 | 0.0 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.0 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.2 | GO:0001881 | receptor recycling(GO:0001881) |
0.0 | 0.1 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.0 | 0.0 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.0 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.0 | 0.6 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.0 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.1 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.7 | GO:0030705 | cytoskeleton-dependent intracellular transport(GO:0030705) |
0.0 | 0.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.0 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 0.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.0 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.0 | 0.0 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.0 | 0.1 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 0.1 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 0.0 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.0 | 0.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.0 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.0 | 0.0 | GO:0002434 | immune complex clearance(GO:0002434) |
0.0 | 0.0 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.0 | 0.0 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.0 | 0.0 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.0 | 0.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.2 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.1 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.0 | 0.0 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.1 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.0 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
0.0 | 0.0 | GO:1904429 | regulation of t-circle formation(GO:1904429) positive regulation of t-circle formation(GO:1904431) |
0.0 | 0.0 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.0 | 0.0 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.1 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.0 | 0.1 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.0 | 0.0 | GO:0060253 | negative regulation of glial cell proliferation(GO:0060253) |
0.0 | 0.0 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.0 | 0.0 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.0 | 0.2 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.1 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.0 | 0.0 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.0 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.0 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.0 | 0.0 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.0 | 0.0 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.0 | 0.0 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.0 | GO:0043650 | dicarboxylic acid biosynthetic process(GO:0043650) |
0.0 | 0.1 | GO:0009060 | aerobic respiration(GO:0009060) |
0.0 | 0.0 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.0 | 0.0 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.0 | 0.0 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.0 | 0.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.1 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 9.1 | GO:0032584 | growth cone membrane(GO:0032584) |
1.1 | 5.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.0 | 2.9 | GO:0072534 | perineuronal net(GO:0072534) |
0.9 | 2.6 | GO:0044393 | microspike(GO:0044393) |
0.8 | 0.8 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.7 | 5.9 | GO:0043083 | synaptic cleft(GO:0043083) |
0.7 | 2.9 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.7 | 2.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.6 | 1.9 | GO:0097441 | basilar dendrite(GO:0097441) |
0.6 | 3.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.6 | 2.4 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.6 | 1.7 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.5 | 1.6 | GO:0097433 | dense body(GO:0097433) |
0.5 | 3.6 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.5 | 1.4 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.5 | 1.4 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.4 | 23.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.4 | 2.7 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.4 | 5.3 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.4 | 3.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.4 | 1.7 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.4 | 9.9 | GO:0044295 | axonal growth cone(GO:0044295) |
0.4 | 0.8 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.4 | 3.3 | GO:0030673 | axolemma(GO:0030673) |
0.4 | 1.1 | GO:0097513 | myosin II filament(GO:0097513) |
0.3 | 1.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.3 | 4.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.3 | 9.2 | GO:0044298 | cell body membrane(GO:0044298) |
0.3 | 2.0 | GO:0043203 | axon hillock(GO:0043203) |
0.3 | 1.0 | GO:0055087 | Ski complex(GO:0055087) |
0.3 | 4.1 | GO:0031045 | dense core granule(GO:0031045) |
0.3 | 3.8 | GO:0071564 | npBAF complex(GO:0071564) |
0.3 | 4.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.3 | 3.0 | GO:0043194 | axon initial segment(GO:0043194) |
0.3 | 7.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.3 | 11.4 | GO:0043198 | dendritic shaft(GO:0043198) |
0.3 | 2.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.3 | 1.1 | GO:0042583 | chromaffin granule(GO:0042583) |
0.3 | 2.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.3 | 0.8 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.3 | 0.3 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.3 | 2.7 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.3 | 1.3 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 39.6 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.3 | 2.0 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 0.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.2 | 1.5 | GO:0032590 | dendrite membrane(GO:0032590) |
0.2 | 0.7 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.2 | 1.7 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 1.0 | GO:0032021 | NELF complex(GO:0032021) |
0.2 | 1.0 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.2 | 0.7 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 1.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 1.6 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 1.8 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 0.9 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 2.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 1.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 11.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.2 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 4.8 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 0.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.2 | 0.6 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 0.8 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 1.0 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 1.2 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 1.9 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 0.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 0.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 5.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.2 | 4.8 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 1.7 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 1.1 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 0.9 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 0.7 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 4.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.2 | 3.5 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 1.4 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.2 | 1.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 0.3 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.2 | 0.7 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 1.0 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 1.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.2 | 0.3 | GO:0097452 | GAIT complex(GO:0097452) |
0.2 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 0.5 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.2 | 0.2 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.2 | 0.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.4 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.1 | 1.0 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 2.1 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 10.3 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 0.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 7.9 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.4 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 0.3 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 0.3 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.1 | 0.7 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.6 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 1.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 1.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.6 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 0.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.9 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.4 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.4 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.4 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 1.5 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.1 | 0.7 | GO:0002177 | manchette(GO:0002177) |
0.1 | 1.1 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 1.0 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 2.2 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 1.7 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.5 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 1.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.3 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.9 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.4 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.3 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.1 | 2.2 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.3 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 30.2 | GO:0045202 | synapse(GO:0045202) |
0.1 | 0.5 | GO:0031082 | BLOC complex(GO:0031082) |
0.1 | 1.0 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 0.5 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.2 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.1 | 1.5 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.3 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 0.5 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.8 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.4 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.7 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.7 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 1.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 1.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 1.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.8 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.4 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 0.6 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.1 | 0.7 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.3 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 0.6 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 4.0 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.3 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.7 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 0.4 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 2.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.6 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.5 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.3 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.4 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 1.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.4 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 1.8 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.3 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.8 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 0.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.2 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 0.6 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 0.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 0.6 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.2 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 2.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.1 | GO:0005712 | chiasma(GO:0005712) |
0.1 | 0.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.3 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.4 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.3 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 2.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.4 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.5 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.3 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.4 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.4 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.0 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.0 | 0.5 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.2 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 0.3 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.0 | 0.7 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.2 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.5 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.1 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 4.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.2 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 1.5 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.7 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.0 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.0 | 9.5 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.1 | GO:0036396 | MIS complex(GO:0036396) |
0.0 | 0.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.4 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.0 | 0.1 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 1.8 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.3 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.3 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 0.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.0 | 0.2 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.3 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.1 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.0 | 0.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.4 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.0 | 0.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.1 | GO:0032437 | cuticular plate(GO:0032437) |
0.0 | 0.1 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 0.4 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 1.1 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 0.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 1.2 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.0 | 0.1 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.3 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.1 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.7 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.1 | GO:0070069 | cytochrome complex(GO:0070069) |
0.0 | 0.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.0 | 0.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.0 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.1 | GO:0035363 | histone locus body(GO:0035363) |
0.0 | 0.0 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.0 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.1 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.0 | 0.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 1.4 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.0 | 0.1 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 0.2 | GO:0044438 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.0 | 0.5 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.7 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.0 | 0.4 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.5 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.5 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.9 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.1 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.0 | 0.0 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.5 | GO:0001533 | cornified envelope(GO:0001533) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 5.7 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
2.1 | 6.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.9 | 5.8 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.8 | 7.1 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.3 | 4.0 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.3 | 5.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.3 | 11.3 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.2 | 6.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.9 | 5.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.8 | 5.1 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.8 | 2.5 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.8 | 2.3 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.7 | 2.9 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.7 | 2.0 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.6 | 5.0 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.6 | 1.9 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.6 | 0.6 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-induced calcium release activity(GO:0048763) |
0.6 | 0.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.6 | 2.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.5 | 3.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.5 | 6.2 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.5 | 1.5 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.5 | 2.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.5 | 3.5 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.5 | 1.5 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.5 | 2.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.5 | 3.6 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.5 | 1.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.5 | 1.8 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.4 | 1.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.4 | 1.3 | GO:0018569 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.4 | 3.4 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.4 | 1.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.4 | 2.9 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.4 | 1.6 | GO:0004952 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.4 | 2.0 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.4 | 3.9 | GO:0051378 | serotonin binding(GO:0051378) |
0.4 | 1.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.4 | 1.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.4 | 1.5 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.4 | 1.9 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.4 | 3.0 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.4 | 1.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.4 | 1.5 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.4 | 2.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.4 | 2.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.4 | 2.9 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.4 | 1.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.4 | 0.7 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.4 | 0.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.3 | 1.0 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.3 | 3.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.3 | 0.7 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.3 | 3.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.3 | 1.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.3 | 2.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.3 | 2.0 | GO:0048495 | Roundabout binding(GO:0048495) |
0.3 | 2.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 1.0 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 1.3 | GO:0034618 | arginine binding(GO:0034618) |
0.3 | 1.6 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.3 | 1.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.3 | 1.6 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.3 | 0.9 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.3 | 1.3 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.3 | 1.2 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.3 | 0.6 | GO:0035939 | microsatellite binding(GO:0035939) |
0.3 | 2.1 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.3 | 7.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.3 | 0.9 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.3 | 0.6 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.3 | 1.8 | GO:0005499 | vitamin D binding(GO:0005499) |
0.3 | 8.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.3 | 0.9 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.3 | 5.1 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.3 | 1.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.3 | 0.8 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.3 | 0.8 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.3 | 1.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.3 | 1.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.3 | 4.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.3 | 0.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 1.9 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 7.8 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.3 | 1.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.3 | 0.8 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.3 | 6.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 0.8 | GO:0097016 | L27 domain binding(GO:0097016) |
0.3 | 0.8 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 0.5 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.2 | 0.7 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.2 | 3.0 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 2.7 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 1.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 1.0 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 0.5 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 1.4 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.2 | 2.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 1.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 0.7 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.2 | 2.5 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 3.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 0.5 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.2 | 2.0 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 2.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 0.9 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 8.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 3.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 2.4 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 1.1 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.2 | 1.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.2 | 1.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.2 | 0.7 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.2 | 5.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 3.5 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 0.6 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.2 | 0.6 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.2 | 1.5 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.2 | 2.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 0.8 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.2 | 3.1 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 0.6 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.2 | 0.8 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 0.6 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.2 | 1.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 1.0 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.2 | 3.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 3.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 2.9 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 3.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 3.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 0.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 0.4 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.2 | 2.5 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.2 | 0.8 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.2 | 2.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 0.6 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 0.6 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.2 | 4.0 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 0.7 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 2.2 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 0.7 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 0.4 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 4.9 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 1.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 0.9 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 3.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 0.5 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.2 | 1.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 0.2 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.2 | 0.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.2 | 0.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 0.2 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.2 | 0.2 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.2 | 0.2 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.2 | 4.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 2.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 0.5 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.2 | 3.0 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.2 | 1.0 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.2 | 1.3 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.2 | 1.9 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.2 | 0.3 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.2 | 0.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 0.3 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.2 | 0.5 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.2 | 0.3 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.6 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.6 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.1 | 0.1 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 2.8 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.1 | 0.7 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 3.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 0.7 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.6 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 3.0 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 2.4 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 1.8 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 0.6 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.7 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.8 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.1 | 1.8 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.5 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.4 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.7 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 1.1 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 1.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 1.1 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.1 | 0.4 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.3 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 1.5 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.1 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 3.4 | GO:0045543 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.1 | 2.0 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 3.0 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 1.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.2 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 0.4 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 0.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 1.6 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 1.2 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.7 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) |
0.1 | 0.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.7 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.5 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 0.3 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 0.3 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.5 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.4 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.1 | 1.4 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.7 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 0.5 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 1.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.3 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 1.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.3 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 1.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.5 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.2 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.4 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.8 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 5.1 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 4.8 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.1 | 0.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 1.1 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 2.5 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 1.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.7 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.8 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 1.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.3 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.6 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 0.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.5 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.4 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 0.2 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.4 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.2 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.1 | 1.9 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.1 | 5.1 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 0.8 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.2 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.8 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 2.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.3 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.3 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.1 | 0.4 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.1 | 0.4 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 0.3 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.7 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.8 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 1.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.2 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.1 | 2.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.7 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.1 | 0.3 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.1 | 1.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.3 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.8 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.1 | 1.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.1 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.1 | 0.2 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.4 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.1 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.1 | GO:2001070 | starch binding(GO:2001070) |
0.1 | 0.2 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.1 | 1.8 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 1.0 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 2.1 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 0.2 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 0.8 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.1 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.1 | 0.2 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 0.3 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 1.2 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.2 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 0.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.7 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.4 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.3 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.1 | 0.1 | GO:0070538 | oleic acid binding(GO:0070538) |
0.1 | 0.1 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.3 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.1 | 7.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.3 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.1 | 0.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.1 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 0.7 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.3 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.5 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 1.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 1.8 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 0.1 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.1 | 0.4 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.1 | 0.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 0.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.9 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 0.1 | GO:0070905 | serine binding(GO:0070905) |
0.1 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.2 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.3 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.3 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 0.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.1 | 0.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 0.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 1.0 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 1.8 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.6 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.1 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.1 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.1 | 0.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 2.5 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 1.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.9 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.1 | GO:0008169 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
0.1 | 0.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.3 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.1 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.2 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 0.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 2.1 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 0.1 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.1 | 0.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.5 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 0.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.2 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 2.0 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.1 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.0 | 0.5 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.2 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.0 | 0.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.0 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.0 | 0.1 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.0 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.0 | 0.4 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.0 | 0.7 | GO:0016896 | 3'-5'-exoribonuclease activity(GO:0000175) exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.0 | 0.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 0.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.3 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 1.0 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 2.5 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.1 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.0 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.0 | 0.2 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.6 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.7 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 0.4 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.2 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.5 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.4 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.0 | 0.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.0 | 0.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.4 | GO:0035870 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.0 | 0.2 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.0 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 0.2 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.1 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.0 | 0.7 | GO:0052736 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
0.0 | 0.0 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.0 | 0.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.0 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.2 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 12.9 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.1 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.0 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.0 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.0 | 1.0 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 2.4 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.0 | 0.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.0 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.0 | 0.2 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.2 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.3 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.0 | 0.0 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.0 | 0.5 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.3 | GO:0034863 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.0 | 0.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.6 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.1 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 3.4 | GO:0003729 | mRNA binding(GO:0003729) |
0.0 | 0.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.1 | GO:0004096 | catalase activity(GO:0004096) |
0.0 | 0.0 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.0 | 0.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 1.9 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.0 | 0.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.2 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.1 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.0 | 0.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.0 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.0 | 0.4 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.0 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.0 | 2.3 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 0.1 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.0 | 0.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.2 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.5 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.0 | 0.7 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.1 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.5 | GO:0043738 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.0 | 0.1 | GO:0046030 | inositol trisphosphate phosphatase activity(GO:0046030) |
0.0 | 0.0 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.0 | 0.4 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.0 | 0.1 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.0 | 0.2 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.1 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.0 | 0.0 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.0 | 0.4 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.0 | 0.0 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.0 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.0 | 0.6 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.0 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.3 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.0 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.0 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.0 | 0.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.0 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.0 | 0.3 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.1 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.0 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.0 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.0 | 0.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.3 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.0 | 0.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.0 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.0 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.0 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.0 | GO:0052745 | inositol phosphate phosphatase activity(GO:0052745) |
0.0 | 0.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.3 | 4.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.3 | 7.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 5.1 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 4.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 5.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 3.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 14.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 4.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 0.5 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 4.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 1.7 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 1.0 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 3.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 2.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 0.2 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 1.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 2.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 24.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 2.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 2.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 3.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 1.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 3.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.9 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 1.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 4.2 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.1 | 1.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 0.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 2.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 1.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.4 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 1.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 1.2 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.2 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 1.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.5 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 1.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.9 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 0.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.7 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.7 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 1.0 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 1.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.9 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.0 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 0.5 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.4 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.5 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.4 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.1 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 1.8 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
1.5 | 1.5 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.9 | 8.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.8 | 12.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.7 | 0.7 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.6 | 15.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.5 | 2.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.4 | 8.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.4 | 7.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.4 | 5.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.4 | 2.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.4 | 2.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.3 | 13.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.3 | 6.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 3.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.3 | 1.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.3 | 1.5 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 3.9 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 0.5 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 3.0 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.2 | 0.4 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.2 | 2.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.2 | 3.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 2.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 2.9 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 8.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 3.8 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 2.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 0.8 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 2.2 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.2 | 0.5 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.2 | 1.9 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 11.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 3.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 1.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 3.8 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
0.2 | 0.2 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.2 | 1.1 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.2 | 1.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 4.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 0.5 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.2 | 1.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 2.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 0.7 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 1.1 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 3.3 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 0.3 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 3.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 1.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 1.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 2.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 3.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.7 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.1 | 1.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 2.9 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 1.0 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.3 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 2.0 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 1.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 1.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 3.7 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 2.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 0.7 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 1.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 0.5 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 3.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.2 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 0.7 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.8 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.1 | 0.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 1.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 1.2 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.1 | 0.3 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 1.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 0.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 0.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 0.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 10.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.7 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 0.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 0.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 2.8 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 0.4 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 1.5 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 0.1 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 3.2 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 0.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 1.7 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.4 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.0 | 0.5 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 1.1 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.3 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.0 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 1.2 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.2 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.5 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 2.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.6 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 1.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.1 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.0 | 0.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.6 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 1.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.0 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.0 | 0.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.5 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 2.8 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 1.0 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.0 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.0 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.2 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 0.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.7 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.3 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.0 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.0 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.0 | 0.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.0 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.0 | 0.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.6 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |